Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1995
11/15/1995EP0682040A1 Humanized immunoglobulins and their production and use
11/15/1995EP0682039A1 CTLA4 molecules and IL4-binding molecules and uses thereof
11/15/1995EP0682006A1 Process for the preparation of a concentrate of esters of polyunsaturated fatty acids
11/15/1995EP0681842A2 Ligand-mediated immunofunctional hormone binding protein assay method
11/15/1995EP0681833A2 Nasally administrable compositions
11/15/1995EP0681787A2 Use of an enzyme for manufacturing an agent for the treatment and/or prophylaxis of coccidiosis
11/15/1995EP0681589A1 Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10
11/15/1995EP0681588A1 Max-interacting proteins and related molecules and methods
11/15/1995EP0681585A1 Tata-binding protein associated factors, nucleic acids encoding tafs, and methods of use
11/15/1995EP0681491A1 Intrapulmonary delivery of hormones
11/15/1995EP0681484A1 Immunoreactive reagents employing heterodimers
11/15/1995EP0681483A1 Compositions and methods for delivery of genetic material
11/15/1995EP0681477A1 Genetic modification of neural stem cells
11/15/1995EP0681470A1 Recombinant living subunit vaccine composition and process for its preparation.
11/15/1995EP0527977B1 Nematode vaccine
11/15/1995EP0448707B1 Bacteria harboring expression vectors encoding human CILIARY NEUROTROPHIC FACTOR (h-CNTF), their use in the production of h-CNTF, antibodies to h-CNTF and the use of h-CNTF in medical treatment
11/15/1995EP0444186B1 Pharmaceutical composition that makes cells expressing mhc class ii antigens targets for cytotoxic t-cells
11/15/1995EP0420913B1 Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same
11/15/1995CN1111910A Mammamodulin, a hormone-independent mammary tumor cells specific protein
11/15/1995CN1111640A Lipopeptide derivatives, a process for their preparation and their use
11/15/1995CN1111630A Adhesion receptor antagonists
11/15/1995CN1111531A Medical nano capsule freezing and drying protective agent
11/15/1995CN1111530A Application of metal sulfur protein in preparing medicine for curing recurrent ulcer of mouth
11/15/1995CN1111505A Medicine membrane for curing stomatocace
11/15/1995CN1030255C Ring groth hormone releasing factor (GRF), analogue and its process
11/14/1995US5466841 Formulations containing unsaturated fatty acids
11/14/1995US5466783 Human tissue factor inhibitor
11/14/1995US5466782 Method for separating a compound containing glycolipids, lysophospholipids, sphingolipids and ceramides of plant origin
11/14/1995US5466696 Tacrine and cytochrome P450 oxidase inhibitors and methods of use
11/14/1995US5466681 Receptor conjugates for targeting penicillin antibiotics to bacteria
11/14/1995US5466673 Glutathione derivative
11/14/1995US5466672 Anticancer
11/14/1995US5466671 Apidaecin-type peptide antibiotics with improved activities and/or different antibacterial spectrum
11/14/1995US5466670 Use of IGF-1
11/14/1995US5466669 Immunostimulatory agent
11/14/1995US5466668 Anticoagulants using nucleic acids
11/14/1995US5466667 Prophylactic and therapeutic methods for treating edema with antamanides
11/14/1995US5466666 Dissolving in propanol/1-/ and buffer; diluting with water; precipitation; disulfide bridges
11/14/1995US5466595 Calcium independent cytosolic phospholipase A2/B enzymes
11/14/1995US5466585 Interferon-induced human protein in pure form, monoclonal antibodies thereto, and test kits containing these antibodies
11/14/1995US5466584 Oxytocin receptor and DNA coding therefor
11/14/1995US5466547 Enteric coated papain-containing food supplement for controlling auto immune diseases
11/14/1995US5466449 Antibacterial composition and method of use
11/14/1995US5466447 Interleukin-2 lymphokine for skin disorders
11/14/1995CA1337548C Fatty acid composition
11/10/1995CA2148963A1 Use of proteins from bovine colostrum to treat failure of passive transfer, to promote growth and to improve milk production in bovine species
11/10/1995CA2148301A1 Expression of recombinant mpf-4, cpf-4, pf-4 and precursor compounds
11/10/1995CA2147390A1 Process for the production of a concentrate of polyunsaturated fatty acid esters
11/09/1995WO1995030016A1 Methods for peptide synthesis and purification
11/09/1995WO1995030015A2 Isolated epstein-barr virus bzlf2 proteins that bind mhc class ii beta chains
11/09/1995WO1995030014A1 Bifunctional protein, preparation and use
11/09/1995WO1995030013A1 Human-origin prostacyclin synthase
11/09/1995WO1995030008A1 Density enhanced protein tyrosine phosphatases
11/09/1995WO1995030007A1 Thymidine kinase mutants
11/09/1995WO1995030004A1 Monoclonal antibodies which promote central nervous system remyelination
11/09/1995WO1995030003A2 Morphogenic protein-specific cell surface receptors and uses therefor
11/09/1995WO1995030002A2 Enhancing the sensitivity of tumor cells to therapies
11/09/1995WO1995030001A2 Novel p-selectin ligand protein
11/09/1995WO1995029987A1 Beta taipoxin as a cell growth factor and method
11/09/1995WO1995029938A1 Antigen/antibody specificity exchanger
11/09/1995WO1995029937A1 A new 78 residue polypeptide (nk-lysine) and its use
11/09/1995WO1995029936A1 Methods for controlling t lymphocyte mediated immune responses
11/09/1995WO1995029933A1 Modified milk growth factor
11/09/1995WO1995029925A1 Thioether compounds for use in preparing bifunctional chelating agents for therapeutic radiopharmaceuticals
11/09/1995WO1995029707A1 Composition for delivery of toxic radioisotopes to the cell nucleus and use
11/09/1995WO1995029703A1 Introduction of hiv-protective genes into cells by particle-mediated gene transfer
11/09/1995WO1995029698A1 Tumor-associated antigen peptides and their use in tumor diagnosis and therapy
11/09/1995WO1995029697A1 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases
11/09/1995WO1995029696A1 Products of lacrimal gland for tear replacement
11/09/1995WO1995029695A1 Epitaxin, a cell motility factor
11/09/1995WO1995029694A1 Collagen hydrolysis accelerator
11/09/1995WO1995029693A1 Methods and compositions for modulating heterotypic e-cadherin interactions with t lymphocytes
11/09/1995WO1995029692A1 An advanced glycosylation endproduct-receptor, and diagnostic and therapeutic methods based thereon
11/09/1995WO1995029691A1 Proline phosphonate derivatives
11/09/1995WO1995029689A1 N-carboxyalkyl derivatives as antidegenerative active agents
11/09/1995WO1995029686A1 Recombinant fibrin chains, fibrin and fibrin-homologs
11/09/1995WO1995029685A1 Activin antagonists as novel contraceptives
11/09/1995WO1995029675A1 Method and composition for treating renal disease and failure
11/09/1995WO1995029673A1 Methods for modulating t cell responses by manipulating intracellular signal transduction
11/09/1995WO1995029669A2 Multifunctional ligand for use as a diagnostic or therapeutic pharmaceutical
11/09/1995WO1995029664A1 Modulated release from biocompatible polymers
11/09/1995WO1995029592A1 Method for control of growth of bacteria, protozoa and fungi
11/09/1995WO1995028166A3 Method for implanting encapsulated cells in a host
11/09/1995DE4445939A1 Neue Aminosäurederivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen (II) New amino acid derivatives, to processes for their preparation containing these compounds and pharmaceutical compositions (II)
11/09/1995DE4415998A1 Neue Tetrapeptide, ihre Herstellung Verwendung New tetrapeptides, their preparation using
11/09/1995DE4415997A1 Neuer peptidischer Wirkstoff und dessen Herstellung New peptidic drug and its preparation
11/09/1995DE4415743A1 Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen Papillomaviruses means for their detection as well as for the treatment of diseases caused by them
11/09/1995DE4415345A1 New peptide antibiotics helioferin A and B from Mycogone rosea
11/09/1995CA2690298A1 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases
11/09/1995CA2189543A1 Thymidine kinase mutants
11/09/1995CA2189425A1 Methods for controlling t lymphocyte mediated immune responses
11/09/1995CA2189357A1 Beta taipoxin as a cell growth factor and method
11/09/1995CA2189070A1 Method and composition for treating renal disease and failure
11/09/1995CA2189032A1 Enhancing the sensitivity of tumor cells to therapies
11/09/1995CA2189005A1 Activin antagonists as novel contraceptives
11/09/1995CA2188647A1 Recombinant fibrin chains, fibrin and fibrin-homologs
11/09/1995CA2188569A1 Multifunctional ligand for use as a diagnostic or therapeutic pharmaceutical
11/09/1995CA2188565A1 Thioether compounds for use in preparing bifunctional chelating agents for therapeutic radiopharmaceuticals
11/09/1995CA2187902A1 Morphogenic protein-specific cell surface receptors and uses therefor
11/09/1995CA2165413A1 Methods for peptide synthesis and purification
1 ... 2818 2819 2820 2821 2822 2823 2824 2825 2826 2827 2828 2829 2830 2831 2832 2833 2834 2835 2836 2837 2838 ... 3163